[Helping the "hard-core" smokers]
J Perriot1, M Underner, G Peiffer
1Dispensaire Émile-Roux, centre de lutte antituberculeux (CLAT 63), centre de tabacologie, 11 rue Vaucanson, Clermont-Ferrand, France. jean.perriot@cg63.fr
Revue Des Maladies Respiratoires
|May 1, 2012
Summary
Highly dependent smokers struggle to quit, facing health risks and complex challenges. This review explores medical treatments and combinations to aid "hard-core" smokers in cessation efforts.
Area of Science:
- Addiction Medicine
- Public Health
- Behavioral Science
Context:
- Many smokers experience severe nicotine dependence, hindering cessation attempts despite motivation or external pressures.
- Factors like anxiety, depression, socioeconomic issues, and co-occurring substance use complicate smoking cessation.
- Highly dependent smokers represent a priority group for smoking cessation clinics, requiring optimized interventions.
Purpose:
- To describe the characteristics of highly dependent smokers who face difficulties in quitting.
- To suggest medical treatments and therapeutic combinations for assisting 'hard-core' smokers.
- To guide smoking cessation specialists in improving interventions for this challenging population.
Summary:
- This review focuses on individuals with heavy tobacco dependence and high cigarette consumption who struggle to quit smoking.
- It highlights associated morbidities and unfavorable factors such as mental health disorders and socioeconomic difficulties.
- The paper proposes medical strategies and combination therapies to support practitioners in treating persistent smokers.
Impact:
- Provides insights into the profile of difficult-to-treat smokers.
- Offers evidence-based treatment suggestions for smoking cessation specialists.
- Aims to improve cessation success rates for highly dependent individuals.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...